Oscar Health Files 8-K for Regulation FD Disclosure

Ticker: OSCR · Form: 8-K · Filed: Sep 4, 2024 · CIK: 1568651

Sentiment: neutral

Topics: regulation-fd, disclosure

Related Tickers: OSCR

TL;DR

Oscar Health dropped an 8-K for a Reg FD disclosure - could be big news.

AI Summary

Oscar Health, Inc. filed an 8-K on September 4, 2024, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, dollar amounts, or specific dates beyond the filing date itself.

Why It Matters

This filing indicates Oscar Health is making a public disclosure under Regulation FD, which could contain material information for investors.

Risk Assessment

Risk Level: medium — The filing is a placeholder for a Regulation FD disclosure, meaning the actual content could be material and impact the stock price.

Key Players & Entities

FAQ

What specific information is being disclosed under Regulation FD?

The provided text of the 8-K filing does not specify the details of the Regulation FD disclosure.

When was the earliest event reported in this filing?

The earliest event reported is September 4, 2024, which is also the date of the report.

What is Oscar Health, Inc.'s principal executive office address?

Oscar Health, Inc.'s principal executive offices are located at 75 Varick Street, 5th Floor, New York, New York 10013.

What is the Commission File Number for Oscar Health, Inc.?

The Commission File Number for Oscar Health, Inc. is 001-40154.

Has Oscar Health, Inc. had a former name or address that was reported?

The filing states 'Not Applicable' for former name or former address, if changed since last report.

Filing Stats: 871 words · 3 min read · ~3 pages · Grade level 14 · Accepted 2024-09-04 06:30:52

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Oscar Health, Inc. Date: September 4, 2024 By: /s/ Ranmali Bopitiya Ranmali Bopitiya Chief Legal Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing